FEFernando Escobar
Fernando Escobar
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fernando Escobar has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Lucia Romero
Centro de Investigación e Innovación en Bioingeniería (Ci2B), Universitat Politècnica de València, Valencia, Spain
4 shared publications - Julio Gomis-Tena
Department of Electronic Engineering, Universitat Politcnica de Valncia, Valencia, Spain
3 shared publications Dan A. Klaerke
Department of Pathobiology, University of Copenhagen, Copenhagen, Denmark
1 shared publicationJavier Saiz
Centro de Investigación e Innovación en Bioingeniería, Universitat Politècnica de València
1 shared publication- Javier Saiz
Centro de Investigación e Innovación en Bioingeniería (CI2B), Universitat Politècnica de València, 46022 Valencia, Spain
1 shared publication Nina Brinkwirth
Nanion Technologies, Munich, Germany
1 shared publication
Latest Publications
- Open Access
- 31 October 2026
- Published by Elsevier in The Journal of Precision Medicine: Health and Disease
- Vol. 8
In silico trials under long QT syndrome conditions using static and dynamic formulations of drugs
- 31 October 2026
- Published by Elsevier in The Journal of Precision Medicine: Health and Disease
- Vol. 8
Open AccessIn silico trials under long QT syndrome conditions using static and dynamic formulations of drugs
- Open Access
- 18 December 2024
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 260, 108566
A simulation study of the impact of drug-IKr binding mechanisms on biomarkers of proarrhythmic risk reveals a crucial role in reverse use-dependence of action potential duration and a marked influence on the vulnerable window
- 18 December 2024
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 260, 108566
Open AccessA simulation study of the impact of drug-IKr binding mechanisms on biomarkers of proarrhythmic risk reveals a crucial role in reverse use-dependence of action potential duration and a marked influence on the vulnerable window
- Open Access
- 22 June 2024
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 254, 108293
Experimentally validated modeling of dynamic drug-hERG channel interactions reproducing the binding mechanisms and its importance in action potential duration.
- 22 June 2024
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 254, 108293
Open AccessExperimentally validated modeling of dynamic drug-hERG channel interactions reproducing the binding mechanisms and its importance in action potential duration.
- Open Access
- 21 September 2022
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 226, 107148
Automatic modeling of dynamic drug-hERG channel interactions using three voltage protocols and machine learning techniques: A simulation study
- 21 September 2022
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 226, 107148
Open AccessAutomatic modeling of dynamic drug-hERG channel interactions using three voltage protocols and machine learning techniques: A simulation study